Medical Affairs Policy
|
|
- Blaze Little
- 6 years ago
- Views:
Transcription
1 Service: Neuropsychological Testing PUM Medical Affairs Policy Medical Policy Committee Approval 03/17/17 Effective Date 07/01/17 Prior Authorization Needed Yes-excluding the neurobehavioral status exam* Disclaimer: This policy is for informational purposes only and does not constitute medical advice, plan authorization, an explanation of benefits, or a guarantee of payment. Benefit plans vary in coverage and some plans may not provide coverage for all services listed in this policy. Coverage decisions are subject to all terms and conditions of the applicable benefit plan, including specific exclusions and limitations, and to applicable state and federal law. Some benefit plans administered by the organization may not utilize Medical Affairs medical policy in all their coverage determinations. Contact customer services as listed on the member card for specific plan, benefit, and network status information. Medical policies are based on constantly changing medical science and are reviewed annually and subject to change. The organization uses tools developed by third parties, such as the evidence-based clinical guidelines developed by MCG to assist in administering health benefits. This medical policy and MCG guidelines are intended to be used in conjunction with the independent professional medical judgment of a qualified health care provider. To obtain additional information about MCG, medical.policies@wpsic.com. Description: Neuropsychological tests (NPT) are evaluations designed to determine the functional consequences of known or suspected brain injury or abnormality through testing of the neurocognitive domains responsible for language, perception, memory, learning, problem solving and adaptation. Neuropsychological test batteries usually involve extensive evaluation of multiple cognitive domains (e.g., attention, orientation, executive function, verbal memory, spatial memory, language, calculations, mental flexibility, and conceptualization). These tests are carried out on patients who have suffered neurocognitive effects of medical disorders that impinge directly or indirectly on the brain. They are standardized, objective and quantitative in nature and require patients to directly demonstrate their level of competence in a particular cognitive domain. They are not a substitution for clinical interviews, medical, neurologic, or psychological examinations, or other diagnostic procedures used to diagnose neuropathology. Rather, when used judiciously in patients with particular neuropsychological problems, they can be an important tool in making specific diagnoses or prognoses after neurologic injury, to aid in treatment planning, and to address questions regarding treatment goals, efficacy, and patient disposition. Neuropsychological testing is also used to differentiate psychiatric from neurological disorders. Determining what specific brain functions are compromised, as well as which cognitive functions are intact, can help differentiate between the two types of disorders and predict the effects of remediation. Page 1 of 9
2 Concussion and Post-concussion syndrome: Neuropsychological testing is increasingly used in assessment and management of sport-related concussion to assist in return to play decisions. There is some evidence that testing such as the ImPACT test may help to improve the accuracy of cognitive assessment post-concussion. There is poor evidence that testing is prognostic for rate of recovery or that it should be used alone as an indicator for return to play or school. There is insufficient evidence that baseline tests alone influence physician decision-making or management of concussion. The validity of pre-competition testing is controversial. Neuropsychological testing and Attention Deficit Hyperactivity Disorder: Diagnosis of ADHD can be accomplished using clinical evaluation procedures including an interview, review of the patient s medical, psychological, academic, and/or employment records, information from collateral sources, screening inventories, substance abuse history and physical exam. Neurologic conditions that can mimic or co-occur with ADHD can be distinguished from ADHD through history and medical examination and specialized psychometric and medical testing. Neuropsychological testing may be indicated in rare circumstances. Indications of Coverage: Note: The provider performing the testing must be a covered provider for the particular illness or injury under the plan, depending on the condition that is being evaluated. A. Neurobehavioral status exam is considered medically necessary to evaluate possible issues with cognitive functioning, determine the need for neuropsychological testing, and/ or evaluate the treatment efficacy of a cognitive issue previously diagnosed (not an all-inclusive list). *The neurobehavioral status exam does not require prior authorization. B. Neuropsychological testing (NPT) is considered medically necessary for the purpose of directing further medical care when all of the following criteria are met: 1. Documentation of a neurobehavioral status exam or thorough evaluation by a neurologist, psychiatrist, or psychologist indicates the need for NPT. 2. When at least one medical condition or situation is present such as but not limited to: a. Head injury (open or closed) b. Stroke c. Brain tumor Page 2 of 9
3 d. Cerebral anoxic or hypoxic episode e. Severe central nervous system infection f. Neoplasm or vascular injury of the central nervous system g. Neurodegenerative disorders (e.g. Lewy body dementia, primary progressive aphasia) h. Demyelinating diseases (e.g., multiple sclerosis) i. Extrapyramidal diseases (e.g., Parkinson s, Huntington s) j. Metabolic encephalopathy after disease stabilization k. Exposure to agents known to be associated with neurodysfunction, (e.g., intrathecal methotrexate, cranial irradiation, lead poisoning). Occupational hazards such as chronic solvent exposure (if a covered benefit) l. A psychiatric diagnosis has been ruled out, or is not responsive to appropriate treatment and testing is requested to provide a differential diagnosis between a psychiatric and neurologic syndrome that is affecting neurocognitive function. (e.g. Complex ADHD with anxiety disorder; autism or other neurodevelopmental disorders, if the diagnosis is in question). m. The presence of unusual, complex, or co-morbid symptoms requiring clarification that only can be accomplished through neuropsychological testing (e.g. worsening symptoms with appropriate treatment for the presumed diagnosis, or differentiating medication related delirium from a progressive process. 3. The neuropsychological tests employed are likely to produce the diagnostic and treatment clarification required and One of the following conditions or situations: a. When there has been a significant mental status change that is not due to a metabolic disorder (such as a diabetic hypoglycemic episode) and the change has not responded to acute medical therapy, OR Page 3 of 9
4 b. When there has been a significant behavioral change, memory loss, inability to perform simple calculations or abstract tasks, organic brain injury, sensory illusions, or other serious circumscribed cognitive deficits, AND a comprehensive medical and psychological evaluation has been unable to establish a diagnosis OR c. Neurologically complicated cases of Attention Deficit Disorder with significant co-morbidities when, despite a comprehensive medical and psychological evaluation, the diagnosis has not been clearly established, or appropriate medical therapy has failed OR d. Re-evaluation of an individual with decreasing cognitive function is requested due to a neurological disorder if the results are intended to guide treatment. NOTE: Time needed for NPT testing varies depending upon the number of tests performed as well as the cognitive and health status of the individual being tested. More than 8 hours of testing requires physician review. C. Post-Concussion evaluation: Non-baseline NPT testing (e.g. ImPACT) by a physician, psychologist, or licensed mental health professional for management of concussion is considered medically necessary. Limitations of Coverage: A. Review contract and endorsements for exclusions and prior authorization or benefit requirements. B. If used for a condition/diagnosis other than as listed in the Indications of Coverage, deny as experimental, investigational, and unproven at affect health outcomes. C. If used for a condition/diagnosis that is listed in the Indications of Coverage, but the criteria are not met, deny as not medically necessary. If not specified as a health plan exclusion, NPT is considered not medically necessary for any of the following: 1. There is no documentation of thorough medical evaluation by a physician (primary care, specialty, or both) prior to the request. Page 4 of 9
5 2. Request is solely to confirm the working diagnosis and treatment plan. 3. There is no documentation of how the testing will benefit the development of the treatment plan. 4. Uncomplicated attention deficit disorder with or without hyperactivity (ADD/ADHD). 5. When the individual has been diagnosed with a neuro-developmental disorder (for example, autism or Asperger s syndrome) unless coverage is required by Federal or State mandate. 6. Testing is for requested educational purposes, such as assessment of learning style, learning disability, academic ability, development of an educational plan, or for uncomplicated Attention Deficit Disorder. 7. Testing is for the purpose of obtaining or maintaining employment, or improving job performance. 8. Testing is ordered or requested pursuant to a condition of parole, probation, or in any way related to judicial or legal purposes. 9. Testing is required or requested by a third party, such as a school or place of employment. 10. Testing is solely for documenting or monitoring treatment efficacy. (e.g. Gordon Continuous Performance Test, Test of Variables of Attention, etc. to document effectiveness of ADHD management) 11. Re-testing done within one year without clear clinical justification 12. Baseline neuropsychological testing in asymptomatic persons 13. Routine testing upon admission for a behavioral health condition 14. Testing of members who are currently engaged in substance misuse, are in withdrawal, or who only recently are abstinent from drugs or alcohol, as testing may be unreliable in such situations Documentation Required: Office notes and reports indicating: a. The referral source, and to whom the results will be conveyed. b. The test(s) proposed for evaluation. Page 5 of 9
6 References: c. The amount of time being requested to complete the evaluation. d. The treatment planning issue that testing is expected to clarify. e. A summary of clinical information, including differential diagnosis, prior evaluation performed to date, and therapies or remediation attempted. 1. American Academy of Clinical Neuropsychology. American Academy of Clinical Neuropsychology (AACN) practice guidelines for neuropsychological assessment and consultation. Clin Neuropsychol Mar; 21(2): American Academy of Pediatrics (AAP). Committee on Quality Improvement, Subcommittee on Attention Deficit/Hyperactivity Disorder. Clinical Practice Guideline: Diagnosis and Evaluation of the Child with Attention Deficit/Hyperactivity Disorder. Pediatrics. 2000; 105(5): American Psychiatric Association. Practice guideline for the Psychiatric Evaluation of Adults. Second Edition. June Available at: Accessed: 29 Aug American Psychological Association, Presidential Task Force on the Assessment of Age-Consistent Memory Decline and Dementia (1998). Guidelines for the evaluation of dementia and age-related cognitive decline. Washington, DC: American Psychological Association. Available at: Accessed: 29 Aug Filipek PA, Accardo PJ, Ashwal S, Baranek GT, Cook EH Jr, Dawson G, Gordon B, Gravel JS, Johnson CP, Kallen RJ, Levy SE, Minshew NJ, Ozonoff S, Prizant BM, Rapin I, Rogers SJ, Stone WL, Teplin SW, Tuchman RF, Volkmar FR. Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology Aug 22; 55(4): Heilbronner RL, Sweet JJ, Attix DK, Krull KR, Henry GK, and Hart RP. Official position of the American academy of clinical neuropsychology on serial neuropsychological assessments: the utility and challenges of repeat test administrations in clinical and forensic contexts The Clinical Neuropsychologist, 24:8, Available at: Accessed: 29 Aug 11. Page 6 of 9
7 7. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology May 8; 56(9): Pliszka S; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention deficit / hyperactivity disorder. J Am Acad Child Adolesc Psychiatry Jul; 46(7): Sweet, Jerry J., et al, National Academy of Neuropsychology/Division 40 of the America Psychological Association Practice Survey of Clinical Neuropsychology in the United States, Part I: Practitioner and Practice Characteristics, Professional Activities and Time Requirements: The Clinical Neuropsychologist, 2002, Vol. 2, pp Sweet, Jerry J., et al, National Academy of Neuropsychology/Division 40 of the America Psychological Association Practice Survey of Clinical Neuropsychology in the United States, Part II: Reimbursement Experiences, Practice economics, Billing Practices, and Incomes: Archives of Clinical Neuropsychology, 18 (2003) pp Lundin, Karen A., DeFilippis, Nick A., Proposed Schedule of Usual and Customary Test Administration Times: The Clinical Neuropsychologist, 1999, Vol. 13, No 4, pp Camara, Wayne J., et al, Psychological Test Usage: Implications in Professional Psychology: Professional Psychology: Research and Practice: 2000, Vol 31, No 2, pp Institute for Clinical Systems Improvement: Health Care Guidelines: Diagnosis and Management of ADHD in Primary Care for School Age Children and Adolescents, Sixth Edition, January 2005 pp Hurley, Gina: National Association of Pupil Services Administrators: The Use of Neuroeducational Evaluations in Public Schools, Hayes Search and Summary: Gordon Diagnostic System to aid in the assessment of ADHD, February 16; Kirkwood MW, Randolph C, Yeates KO. Returning pediatric athletes to play after concussion: the evidence (or lack thereof) behind baseline neuropsychological testing. Acta Paediatr Sep; 98(9): Page 7 of 9
8 17. Mayers LB, Redick TS. Clinical utility of ImPACT assessment for postconcussion return-to-play counseling: psychometric issues. J Clin Exp Neuropsychol. 2012; 34(3): Epub 2011 Dec McCrory P, Meeuwisse W, Johnston K, Dvorak J, Aubry M, Molloy M, Cantu R. Consensus statement on Concussion in Sport 3rd International Conference on Concussion in Sport held in Zurich, November Clin J Sport Med May; 19(3): Hayes Search & Summary. Uses for Immediate Post-Concussion Assessment and Cognitive Testing (Impact) after Sports-Related Head Injury. May 16, UpToDate Concussion and mild traumatic brain injury. Literature review current through: Dec This topic last updated: Apr 29, UpToDate Postconcussion Syndrome. Literature review current through: Dec This topic last updated: Oct MCG 21 st Edition: ORG: B-805-T (BHG) Neuropsychological Testing. 23. Hayes Medical Technology Directory. Computerized Neurocognitive Testing (CNT) for Sports-Related Head Injury. Publication Date: January , Annual Review Jan 12, UpToDate Evaluation of cognitive impairment and dementia. Literature review current through: December This topic last updated: Aug, 3, UpToDate. ADHD in children and adolescents: Clinical Features and Diagnosis. Literature current through Dec Topic last updated Jan 04, UpToDate. Concussion in children and adolescents: Management. Literature review current through Dec Topic last updated Jan11, Gaudet CE and Weyandt LL. Immediate Post-Concussion and Cognitive Testing (ImPACT): a systematic review of the prevalence and assessment of invalid performance. Clin Neuropsychol Jan;31(1): doi: / Epub 2016 Aug Hang B, Babcock L, Hornung R, et. al. Can Computerized Neuropsychological Testing in the Emergency Department Predict Recovery for Young Athletes With Concussions? Pediatr Emerg Care Oct;31(10): doi: /PEC Page 8 of 9
9 WPS / Arise Review History: Implemented 04/04/14, 04/17/15, 07/01/16, 07/01/17 Reviewed 03/07/14, 03/13/15, 03/11/16, 03/17/17 Revised 03/07/14, 03/13/15, 03/11/16, 03/17/17 Developed Medical Policy 03/07/14, 03/13/15, 03/11/16, 03/17/17 Committee Approval Approved by the Medical Director Page 9 of 9
Neuropsychological Testing Coverage Guidelines
Origination: 5/14/04 Revised: 8/24/16 Annual Review: 11/10/16 Purpose: To provide neuropsychological testing guidelines for the Medical Department staff to reference when making benefit determinations.
More informationMEDICAL POLICY No R4 NEUROPSYCHOLOGICAL AND PSYCHOLOGICAL TESTING
NEUROPSYCHOLOGICAL AND PSYCHOLOGICAL TESTING Effective Date: October 1, 2015 Review Dates: 7/07, 6/08, 6/09, 8/09, 8/10, 8/11, 8/12, 8/13, 8/14, 8/15, 8/16, 8/17 Date Of Origin: July 2007 Status: Current
More informationADMINISTRATIVE POLICY AND PROCEDURE
Page 1 of 5 SECTION: Medical SUBJECT: Neuropsychological and Psychological Testing DATE OF ORIGIN: 2/13/13 REVIEW DATES: 7/17/15 EFFECTIVE DATE: 12/15/16 APPROVED BY: EXECUTIVE DIRECTOR MEDICAL DIRECTOR
More informationClinical Policy Title: Neuropsychological testing
Clinical Policy Title: Neuropsychological testing Clinical Policy Number: 09.01.08 Effective Date: October 1, 2015 Initial Review Date: June 17, 2015 Most Recent Review Date: July 20, 2017 Next Review
More informationMedical Affairs Policy
Service: Acupuncture Therapy PUM 250-0002-1803 Medical Affairs Policy Medical Policy Committee Approval 03/16/18 Effective Date 07/01/18 Prior Authorization Needed Yes-if not an exclusion of the health
More informationMEDICAL POLICY SUBJECT: PSYCHOLOGICAL TESTING. POLICY NUMBER: CATEGORY: Behavioral Health
MEDICAL POLICY SUBJECT: PSYCHOLOGICAL TESTING PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
More informationNeuropsychological Testing (NPT)
Neuropsychological Testing (NPT) POLICY Psychological testing (96101-03) refers to a series of tests used to evaluate and treat an individual with emotional, psychiatric, neuropsychiatric, personality
More informationPsychological & Neuropsychological Test
An Independent Licensee of the Blue Cross and Blue Shield Association Psychological & Neuropsychological Test BEACON HEALTH STRATEGIES, LLC ORIGINAL EFFECTIVE DATE HAWAII LEVEL OF CARE CRITERIA 2013 CURRENT
More informationMedical Affairs Policy
Medical Affairs Policy Service: Urine Drug/Alcohol Screening and Testing PUM 250-0013-1803 Medical Policy Committee Approval 03/06/18 Effective Date 07/01/18 Prior Authorization Needed No Disclaimer: This
More informationClinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT)
Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT) Clinical Policy Number: 09.01.02 Effective Date: September 1, 2013 Initial Review Date: February 18, 2013 Most
More informationMEDICAL POLICY MEDICAL POLICY DETAILS POLICY STATEMENT POLICY GUIDELINES. Page: 1 of 5
Page: 1 of 5 MEDICAL POLICY MEDICAL POLICY DETAILS Medical Policy Title PSYCHOLOGICAL TESTING Policy Number 3.01.02 Category Behavioral Health Effective Date 10/18/01 Revised Date 03/28/02, 03/27/03, 2/26/04,
More informationEmpire BlueCross BlueShield Professional Commercial Reimbursement Policy
Subject: Documentation Guidelines for Central Nervous System Assessments and Tests NY Policy: 0046 Effective: 12/01/2014 11/30/2015 Coverage is subject to the terms, conditions, and limitations of an individual
More informationClinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT)
Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT) Clinical Policy Number: 09.01.02 Effective Date: September 1, 2013 Initial Review Date: February 18, 2013 Most
More informationMedical Affairs Policy
Medical Affairs Policy Service: Blepharoplasty, Blepharoptosis Repair, Brow lift, and Related Procedures PUM 250-0004 Medical Policy Committee Approval 03/16/18 Effective Date 07/01/18 Prior Authorization
More informationMedicare Part C Medical Coverage Policy
Medicare Part C Medical Coverage Policy Neuropsychological Testing Origination: September 19, 2001 Review Date: February 21, 2018 Next Review: February, 2020 DESCRIPTION OF PROCEDURE SERVICE Neuropsychological
More informationDemystifying the Neuropsychological Evaluation Report. Clinical Neuropsychologist 17 March 2017 Program Director, Neurobehavioral Program
Demystifying the Neuropsychological Evaluation Report Jennifer R. Cromer, PhD BIAC Annual Conference Clinical Neuropsychologist 17 March 2017 Program Director, Neurobehavioral Program 84% of neuropsychologists
More informationMedical Affairs Policy
Medical Affairs Policy Service: Back Pain Procedures-Epidural Injection (Caudal Epidural, Selective Nerve Root Block, Interlaminar, Transforaminal, Translaminar Epidural Injection) PUM 250-0015-1706 Medical
More informationMedical Affairs Policy
Medical Affairs Policy Service: Blepharoplasty, Blepharoptosis Repair, Brow lift, and Related Procedures PUM 250-0004 Medical Policy Committee Approval 03/17/17 Effective Date 07/01/17 Prior Authorization
More informationApplied Behavior Analysis for Autism Spectrum Disorders
Applied Behavior Analysis for Autism Spectrum Disorders I. Policy University Health Alliance (UHA) will reimburse for Applied Behavioral Analysis (ABA), as required in relevant State of Hawaii mandates,
More informationRelated Research. 370 Huntington Hall Syracuse NY (315)
Related Research Bara, B.G., Bucciarelli, M., & Colle, L. (2001). Communicative abilities in autism: Evidence for attentional deficits. Brain and Language, 77, 216-240. We suggest that FC allows autistics
More informationMedical Affairs Policy
Medical Affairs Policy Service: Corneal Treatments and Specialized Contact Lenses (Corneal remodeling, Corneal transplant, Corneal collagen crosslinking, Intrastromal Rings- INTACS, Keratoconus treatments,
More informationMEDICAL POLICY SUBJECT: COGNITIVE REHABILITATION. POLICY NUMBER: CATEGORY: Therapy/Rehabilitation
MEDICAL POLICY SUBJECT: COGNITIVE REHABILITATION PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product (including
More informationCigna Medical Coverage Policy
Cigna Medical Coverage Policy Subject Neuropsychological Testing Table of Contents Coverage Policy... 1 General Background... 2 Coding/Billing Information... 17 References... 28 Effective Date... 7/15/2015
More informationTESTING GUIDELINES PerformCare: HealthChoices. Guidelines for Psychological Testing
TESTING GUIDELINES PerformCare: HealthChoices Guidelines for Psychological Testing Testing of personality characteristics, symptom levels, intellectual level or functional capacity is sometimes medically
More informationAdmission Criteria Continued Stay Criteria Discharge Criteria. All of the following must be met: 1. Member continues to meet all admission criteria
CMS Local Coverage Determination (LCD) of Psychiatry and Psychology Services for Massachusetts, New York, and Rhode Island L33632 Outpatient Services Coverage Indications and Limitations Hospital outpatient
More informationthe health outcomes or benefits associated with this procedure.
Original Issue Date (Created): October 4, 2002 Most Recent Review Date (Revised): March 25, 2014 Effective Date: June 1, 2014 I. POLICY Cognitive rehabilitation may be considered medically necessary for
More informationUniversity of the West Indies, Kingston, Jamaica PLEASE SCROLL DOWN FOR ARTICLE
This article was downloaded by:[ryerson University] On: 4 June 2008 Access Details: [subscription number 789542258] Publisher: Routledge Informa Ltd Registered in England and Wales Registered Number: 1072954
More informationMedical Affairs Policy
Medical Affairs Policy Service: Back Pain: Sacroiliac and Coccydynia Treatments PUM 250-0024-1706 Medical Policy Committee Approval 06/15/18 Effective Date 10/01/18 Prior Authorization Needed Yes Disclaimer:
More informationMedical Affairs Policy
Medical Affairs Policy Service: Omnibus Pharmacy Policy for Treatments Reviewed by Medical Affairs PUM 250-0037-1712 Medical Policy Committee Approval 12/01/17 Effective Date 04/01/18 Prior Authorization
More informationPre and Post Concussion Management
Pre and Post Concussion Management Timothy A. Tolbert, Ph.D., ATC Clinical Coordinator Marshall University Athletic Training Program 1 Concussion A complex pathophysiological process affecting the brain,
More informationSeptember 12, Richard Hodges Director, Ohio Department of Health 246 N. High St. Columbus, Ohio 43215
September 12, 2014 Richard Hodges Director, Ohio Department of Health 246 N. High St. Columbus, Ohio 43215 RE: Offer of consultation regarding the creation of guidelines on the diagnosis, treatment and
More informationClinical Policy: EEG in the Evaluation of Headache Reference Number: CP.MP.155
Clinical Policy: EEG in the Evaluation of Headache Reference Number: CP.MP.155 Effective Date: 12/17 Last Review Date: 12/17 Coding Implications Revision Log See Important Reminder at the end of this policy
More informationBehavioral Health Clinician in Primary Care Billing & Coding Guidance (Created September 2017)
Behavioral Health Clinician in Primary Care Billing & Coding Guidance (Created September 2017) This information was drafted by behavioral leaders interested in supporting optimal billing for behavioral
More informationEarly Screening of ASD & The Role of the SLP
Early Screening of ASD & The Role of the SLP Objectives Identify reasons for early identification Identify screenings tools that aid in identification of ASD Define the role of the SLP in screening & assessment
More informationArise Medical Policy Updates
Arise Medical Policy Updates The Medical Affairs Medical Policy Committee approved medical policies on March 16, 2018. The policies become effective July 1, 2018, unless otherwise noted below. Disclaimer:
More informationPost Concussion Instructions and Return to Play Clearance Form
Post Concussion Instructions and Return to Play Clearance Form R e v i s e d & Updated August 11, 2011 From:, at High School Name of School Representative* Name of School Position of School Representative*,
More informationINTERQUAL BEHAVIORAL HEALTH CRITERIA ADOLESCENT PSYCHIATRY REVIEW PROCESS
INTERQUAL BEHAVIORAL HEALTH CRITERIA ADOLESCENT PSYCHIATRY REVIEW PROCESS RP-1 RP-2 AGE PARAMETERS Adolescent Psychiatry Behavioral Health Criteria are for the review of patients who are ages 13 to 17
More informationPharmacy Medical Necessity Guidelines: ADHD CNS Stimulant Medications
Pharmacy Medical Necessity Guidelines: ADHD CNS Stimulant Medications Effective: January 1, 2018 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy
More informationClinical Policy: Lisdexamfetamine (Vyvanse) Reference Number: CP. PPA.03. Line of Business: Medicaid
Clinical Policy: (Vyvanse) Reference Number: CP. PPA.03 Effective Date: 02/09 Last Review Date: 05/17 Line of Business: Medicaid Coding Implications Revision Log See Important Reminder at the end of this
More informationPharmacy Medical Necessity Guidelines: CNS Stimulant Medications
Pharmacy Medical Necessity Guidelines: CNS Stimulant Medications Effective: June 1, 2017 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy
More informationBaseline Characteristics of Patients Attending the Memory Clinic Serving the South Shore of Boston
Article ID: ISSN 2046-1690 Baseline Characteristics of Patients Attending the www.thealzcenter.org Memory Clinic Serving the South Shore of Boston Corresponding Author: Dr. Anil K Nair, Chief of Neurology,
More informationSports Neuropsychology: Definition, Qualifications, and Training Guidelines
Sports Neuropsychology: Definition, Qualifications, and Training Guidelines An Official Position of the Sports Neuropsychology Society Preamble Clinical neuropsychology has a long history, and clinical
More informationATTENTION DEFICIT DISORDER; AEROMEDICAL CONSIDERATIONS
ATTENTION DEFICIT DISORDER; AEROMEDICAL CONSIDERATIONS David Bryman, D.O Senior International Aviation Medical Examiner FAA, EASA, Australia, New Zealand, Canada drbryman@gmail.com Disclosure Information
More informationGlenn T. Goodwin, Ph.D. gtgphd.com
CREDENTIALS EDUCATION EMPLOYMENT Licensed Psychologist (Washington) Diplomate, American Board of Forensic Examiners Diplomate, American Board of Psychological Specialties: Forensic Neuropsychology (American
More informationDepartmental Concussion Guidelines
Concussion Plan Departmental Concussion Guidelines The following guidelines have been developed in accordance with Alabama A&M s Mission Statement and service goal of providing quality healthcare services
More informationReports of the INS - Division 40 Task Force on Education, Accreditation, and Credentialing
The Clinical Neuropsychologist 1987, Vol. 1, nr. 1, pp. 29-34 0920-1637/87/0 10 1-0029$3.00 Q Swets & Zeitlinger Reports of the INS - Division 40 Task Force on Education, Accreditation, and Credentialing
More informationClinical Neuropsychology Residency Program. Department of Health Psychology in the School of Health Professions
Clinical Neuropsychology Residency Program Department of Health Psychology in the School of Health Professions Last Updated: 11/16/2017 1 Program description: The post-doctoral residency program in neuropsychology
More information01/26/17. Replaces Effective Policy Dated: Autism Spectrum Disorders in Children: Assessment 01/19/16 and Evaluation Reference #: MP/A005 Page 1 of 4
Reference #: MP/A005 Page 1 of 4 PRODUCT APPLICATION: PreferredOne Administrative Services, Inc. (PAS) ERISA PreferredOne Administrative Services, Inc. (PAS) Non-ERISA PreferredOne Community Health Plan
More informationComplete Summary GUIDELINE TITLE
Complete Summary GUIDELINE TITLE Practice parameter: screening and diagnosis of autism. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society.
More informationMEDICARE COVERAGE SUMMARY: PSYCHOLOGICAL AND NEUROPSYCHOLOGICAL TESTING
OPTUM MEDICARE COVERAGE SUMMARY: PSYCHOLOGICAL AND NEUROPSYCHOLOGICAL TESTING MEDICARE COVERAGE SUMMARY: PSYCHOLOGICAL AND NEUROPSYCHOLOGICAL TESTING Guideline Number: BH803MAPNT_01 Effective Date: January,
More informationHill, Elisabeth L Executive dysfunction in autism. Trends in Cognitive Sciences, 8(1), pp ISSN [Article]
Hill, Elisabeth L.. 2004. Executive dysfunction in autism. Trends in Cognitive Sciences, 8(1), pp. 26-32. ISSN 13646613 [Article] http://research.gold.ac.uk/2558/ The version presented here may differ
More informationReferrer Resource Pack. Neurocognitive Clinic
Referrer Resource Pack Neurocognitive Clinic Each Neurocognitive Clinic Assessment is tailored to the individual, dependent upon a number of factors, including their symptoms, current level of functioning
More informationTraumatic Brain Injury for VR Counselors Margaret A. Struchen, Ph.D. and Laura M. Ritter, Ph.D., M.P.H.
Training Session 3a: Understanding Roles of Members of the Interdisciplinary Treatment Team, Evaluations by Team Members and the Utility of Evaluations Conducted by such Team Members. The Interdisciplinary
More informationDocket No CMH Decision and Order
3. Following the most recent assessment of Appellant s status in the program, the CMH determined that Appellant would age out of the autism ABA benefit but would be eligible for ongoing DD services. Testimony
More informationQuality of Life Among Adults with Attention Deficit Hyperactivity Disorder (ADHD): Comparative Study Between the Three Presentations of ADHD
University of Kentucky UKnowledge Theses and Dissertations--Early Childhood, Special Education, and Rehabilitation Counseling Early Childhood, Special Education, and Rehabilitation Counseling 2015 Quality
More informationINTERQUAL BEHAVIORAL HEALTH CRITERIA GERIATRIC PSYCHIATRY REVIEW PROCESS
INTERQUAL BEHAVIORAL HEALTH CRITERIA GERIATRIC PSYCHIATRY REVIEW PROCESS RP-1 RP-2 AGE PARAMETERS Geriatric Psychiatry Behavioral Health Criteria are for the review of patients who are ages 65 and older.
More informationPSYCHOTROPIC MEDICATION UTILIZATION PARAMETERS FOR CHILDREN AND YOUTH IN FOSTER CARE
PSYCHOTROPIC MEDICATION UTILIZATION PARAMETERS FOR CHILDREN AND YOUTH IN FOSTER CARE Introduction and General Principles April 2017 Adapted for New Mexico from with permission from the Texas Department
More informationNo An act relating to health insurance coverage for early childhood developmental disorders, including autism spectrum disorders. (S.
No. 158. An act relating to health insurance coverage for early childhood developmental disorders, including autism spectrum disorders. (S.223) It is hereby enacted by the General Assembly of the State
More informationMedical Affairs Policy
Medical Affairs Policy Service: Cochlear Implants, Bone Anchored Hearing Aids (BAHA), Auditory Brainstem Implants, and Other Hearing Assistive Devices PUM 250-0014 Medical Policy Committee Approval 06/15/18
More informationBehavioral Health Services An essential, coding, billing and reimbursement resource for psychiatrists, psychologists, and clinical social workers
CODING & PAYMENT GUIDE 2019 Behavioral Health Services An essential, coding, billing and reimbursement resource for psychiatrists, psychologists, and clinical social workers Power up your coding optum360coding.com
More informationMichael J. O Brien, MD, Director William P. Meehan III, MD
Michael J. O Brien, MD, Director William P. Meehan III, MD Sports Concussion Clinic Division of Sports Medicine Boston Children s Hospital Disclosures No conflicts of interest related to this discussion
More informationUsing Neuropsychological Experts. Elizabeth L. Leonard, PhD
Using Neuropsychological Experts Elizabeth L. Leonard, PhD Prepared for Advocate. Arizona Association for Justice/Arizona Trial Lawyers Association. September, 2011 Neurocognitive Associates 9813 North
More informationDr Mark Fulcher Sports and Exercise Medicine Physician Axis Sports Medicine Specialists
Dr Mark Fulcher Sports and Exercise Medicine Physician Axis Sports Medicine Specialists 16:30-17:25 WS #163: ACC Sports Concussion Guidelines 17:35-18:30 WS #175: ACC Sports Concussion Guidelines (Repeated)
More informationReview of: NATA Position Statement Management of Sport Concussion.
Review of: NATA Position Statement Management of Sport Concussion www.csm-institute.com Topics: Education and Prevention Documentation and Legal Aspects Evaluation and RTP Other Considerations Strength
More informationFactors related to neuropsychological deficits in ADHD children
Factors related to neuropsychological deficits in ADHD children MD S. DRUGĂ Mindcare Center for Psychiatry and Psychotherapy, Child and Adolescent Psychiatry Department, Bucharest, Romania Clinical Psychologist
More informationModel Intervention for Students with Substance Abuse Problems Act
Model Intervention for Students with Substance Abuse Problems Act MODEL INTERVENTION FOR STUDENTS WITH SUBSTANCE ABUSE PROBLEMS ACT Table of Contents G-103 Policy Statement G-105 Highlights Section One
More informationPharmacy Medical Necessity Guidelines: ADHD CNS Stimulant Medications
Pharmacy Medical Necessity Guidelines: ADHD CNS Stimulant Medications Effective: November 13, 2018 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review
More informationClinical Policy: Multiple Sleep Latency Testing
Clinical Policy: Reference Number: CP.MP.24 Last Review Date: 04/18 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description
More informationThe Impact of Autism on Child Development
AUTISM The Impact of Autism on Child Development Wendy L. Stone, PhD, Lauren Turner, PhD Vanderbilt Centre for Child Development, USA August 2005 Introduction Autism is a developmental disorder characterized
More informationADHD Guidance September 2013
ADHD Guidance September 2013 This guidance has been developed from the SASC convened ADHD Consensus Meeting chaired by Prof Philip Asherson held at Oxford University in May 2013 and subsequent consultations
More informationTIMOTHY D MCMANUS, PSYD., ABPP-RP, ABN Curriculum Vitae
TIMOTHY D MCMANUS, PSYD., ABPP-RP, ABN Curriculum Vitae Education: 1969 1973 Western Illinois University Macomb, IL Degree: B.S. Psychology 1976 1977 Southern Illinois University Carbondale, IL Degree:
More informationAbout Cognition. See Diagnosis Specific Information Section. Autism Spectrum Disorders (ASD) Traumatic Brain Injury (TBI)
About Cognition Intellectual disability is a disability characterized by significant limitations both in intellectual functioning (reasoning, learning, problem solving) and in adaptive behavior, which
More informationReimbursement Guide. Physical Performance Testing For Balance Assessment. September 18 th, Copyright 2013 Sway Medical LLC
Reimbursement Guide Physical Performance Testing For Balance Assessment September 18 th, 2013 The enclosed reimbursement recommendations are based on information gathered from thirdparty sources and is
More informationCharles P. Sabatino ABA Commission on Law and Aging May 20, 2009
Diminished Capacity: How to Recognize It and What to Do About It? Charles P. Sabatino ABA Commission on Law and Aging May 20, 2009 Assessment of Older Adults with Diminished Capacity: A Handbook for Lawyers
More informationDIAGNOSIS FOR BAP SUPPLEMENTAL BENEFITS
INJURY DEFINITIONS DIAGNOSIS FOR BAP SUPPLEMENTAL BENEFITS Level 1 Neurocognitive Impairment of Level 1 Neurocognitive Impairment must meet the criteria set forth in subsections (i)-(iv) informant, or
More informationVersion of record first published: 25 Apr 2012.
This article was downloaded by: [Dr William T. Tsushima] On: 23 October 2012, At: 13:21 Publisher: Psychology Press Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered office:
More informationMedical Necessity Guidelines: Applied Behavioral Analysis (ABA) including Early Intervention for RITogether
Medical Necessity Guidelines: Applied Behavioral Analysis (ABA) including Effective: August 1, 2017 Clinical Documentation and Prior Authorization Required Applies to: Coverage Guideline, No prior Authorization
More informationRole of Neuropsychology Concussion Management. Aimee Custer, PsyD Clinical Sports Neuropsychologist
Role of Neuropsychology Concussion Management Aimee Custer, PsyD Clinical Sports Neuropsychologist Disclosures I have no disclosures Objectives Understand the differences between Neurocognitive test and
More informationPEDIATRIC SPORTS RELATED CONCUSSIONS
Anna Mazur, PhD PEDIATRIC SPORTS RELATED CONCUSSIONS Disclosure No financial interests or funding 1 Presentation Outline Prevalence Predicting recovery: Post Traumatic Amnesia and Loss of Consciousness
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationApplied Behavior Analysis Therapy for Treatment of Autism Spectrum Disorder
Applied Behavior Analysis Therapy for Treatment of Autism Spectrum Disorder Policy Number: Original Effective Date: MM.12.022 01/01/2016 Line(s) of Business: Current Effective Date: HMO; PPO; Fed 87; FEP;
More informationCorporate Medical Policy
Corporate Medical Policy Quantitative Electroencephalography as a Diagnostic Aid for Attention File Name: Origination: Last CAP Review: Next CAP Review: Last Review: quantitative_electroencephalography_as_a_diagnostic_aid_for_adhd
More informationClinical Policy: Lisdexamfetamine (Vyvanse) Reference Number: CP.PMN.121 Effective Date: Last Review Date: Line of Business: Medicaid
Clinical Policy: (Vyvanse) Reference Number: CP.PMN.121 Effective Date: 02.01.09 Last Review Date: 05.18 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important
More informationDSM-5 MAJOR AND MILD NEUROCOGNITIVE DISORDERS (PAGE 602)
SUPPLEMENT 2 RELEVANT EXTRACTS FROM DSM-5 The following summarizes the neurocognitive disorders in DSM-5. For the complete DSM-5 see Diagnostic and Statistical Manualof Mental Disorders, 5th edn. 2013,
More informationUDS version 3 Summary of major changes to UDS form packets
UDS version 3 Summary of major changes to UDS form packets from version 2 to VERSION 3 february 18 final Form A1: Subject demographics Updated question on principal referral source to add additional options
More informationSENATE, No STATE OF NEW JERSEY. 217th LEGISLATURE INTRODUCED MARCH 14, 2016
SENATE, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED MARCH, Sponsored by: Senator CHRISTOPHER "KIP" BATEMAN District (Hunterdon, Mercer, Middlesex and Somerset) SYNOPSIS Requires certain health benefits
More informationDear Newport News Athletic Parent/Guardian:
Dear Newport News Athletic Parent/Guardian: According to the Children s Hospital of the King s Daughter about one in ten local athletes in contact sports will sustain a concussion during a sports season.
More informationNeuropsychological Evaluations of Capacity STEVEN E. ROTHKE, PH.D., ABPP HAYLEY AMSBAUGH, M.S.
Neuropsychological Evaluations of Capacity STEVEN E. ROTHKE, PH.D., ABPP HAYLEY AMSBAUGH, M.S. Qualifications of Neuropsychologists Doctoral degree in psychology from an accredited university training
More informationClinical Policy: Lisdexamfetamine (Vyvanse) Reference Number: NH.PMN.36 Effective Date: Last Review Date: Line of Business: Medicaid
Clinical Policy: Lisdexamfetamine (Vyvanse) Reference Number: NH.PMN.36 Effective Date: 02.09 Last Review Date: 02.19 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy
More informationIndividuals wishing to seek an evaluation for ADHD
9 WHAT WE KNOW Diagnosis of ADHD in Adults Individuals wishing to seek an evaluation for ADHD should use this information and resource sheet as a set of guidelines for what to expect from the clinician
More informationKendra L. Bryant, Ph.D., ABPP- Clinical Neuropsychology EDUCATION Northeastern University Boston College Wellesley College:
Kendra L. Bryant, Ph.D., ABPP- Clinical Neuropsychology Board Certified by the American Board of Professional Psychology in Clinical Neuropsychology Licensed Psychologist: State of Maine (#PS1009) Neuropsychology
More informationNEUROPSYCHOLOGY TRACK COORDINATOR: Dr. Ellen Vriezen
NEUROPSYCHOLOGY TRACK COORDINATOR: Dr. Ellen Vriezen The Neuropsychology Track offers two Resident Positions: NMS Code Number: 181516 1 position with an Adult emphasis, which provide training for residents
More informationNew Study Confirms the Clinical Usefulness of the ImPACT Baseline ImPACT Testing Model VOL. 2 - FALL 2014
VOL. 2 - FALL 214 New Study Confirms the Clinical Usefulness of the ImPACT Baseline ImPACT Testing Model Authors: Philip Schatz, Stacey obertshaw. Archives of Clinical Neuropsychology. doi: 1.19/arclin/acu41.
More informationNEUROPSYCHOLOGY SERVICE
NEUROPSYCHOLOGY SERVICE Thank you for your interest in the Neuropsychology Service. We specialize in the examination of the relationships between brain function and behavior in a wide variety of neurological
More informationBehavioral and Early Intervention Reviews/Research
Behavioral and Early Intervention Reviews/Research INDEPENDENT REVIEWS OF EARLY INTENSIVE BEHAVIORAL INTERVENTION Report of the Maine Administrators of Services for Children with Disabilities: Over 30
More informationKendra L. Bryant, Ph.D., ABPP- Clinical Neuropsychology EDUCATION Northeastern University Boston College Wellesley College: CLINICAL EXPERIENCE
Kendra L. Bryant, Ph.D., ABPP- Clinical Neuropsychology Board Certified by the American Board of Professional Psychology in Clinical Neuropsychology Licensed Psychologist: State of Maine (#PS1009) Neuropsychology
More informationNUMERATOR: All patients with a diagnosis of Parkinson s Disease who were assessed for cognitive impairment or dysfunction in the past 12 months
Quality ID #291: Parkinson s Disease: Cognitive Impairment or Dysfunction Assessment for Patients with Parkinson s Disease National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area:
More informationFinnish practices: Cognitive assessment and interventions
Finnish practices: Cognitive assessment and interventions Kati Peltonen, psychologist, MSc, MA University of Helsinki, Clinical Neuropsychology Research Group Cognitive assessment and interventions 1.
More informationMEDICAL POLICY SUBJECT: NEUROPSYCHOLOGICAL TESTING. POLICY NUMBER: CATEGORY: Contract Clarification
MEDICAL POLICY SUBJECT: NEUROPSYCHOLOGICAL PAGE: 1 OF: 12 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including an
More information16 SB 319/AP. Senate Bill 319 By: Senators Jackson of the 2nd, Kirk of the 13th, Unterman of the 45th, Henson of the 41st and Orrock of the 36 th
1 2 3 4 5 6 7 8 9 10 11 12 13 Senate Bill 319 By: Senators Jackson of the 2nd, Kirk of the 13th, Unterman of the 45th, Henson of the 41st and Orrock of the 36 th AS PASSED A BILL TO BE ENTITLED AN ACT
More information